Literature DB >> 26096795

Proteolytic cleavage, trafficking, and functions of nuclear receptor tyrosine kinases.

Mei-Kuang Chen1,2, Mien-Chie Hung1,2,3,4.   

Abstract

Intracellular localization has been reported for over three-quarters of receptor tyrosine kinase (RTK) families in response to environmental stimuli. Internalized RTK may bind to non-canonical substrates and affect various cellular processes. Many of the intracellular RTKs exist as fragmented forms that are generated by γ-secretase cleavage of the full-length receptor, shedding, alternative splicing, or alternative translation initiation. Soluble RTK fragments are stabilized and intracellularly transported into subcellular compartments, such as the nucleus, by binding to chaperone or transcription factors, while membrane-bound RTKs (full-length or truncated) are transported from the plasma membrane to the ER through the well-established Rab- or clathrin adaptor protein-coated vesicle retrograde trafficking pathways. Subsequent nuclear transport of membrane-bound RTK may occur via two pathways, INFS or INTERNET, with the former characterized by release of receptors from the ER into the cytosol and the latter characterized by release of membrane-bound receptor from the ER into the nucleoplasm through the inner nuclear membrane. Although most non-canonical intracellular RTK signaling is related to transcriptional regulation, there may be other functions that have yet to be discovered. In this review, we summarize the proteolytic processing, intracellular trafficking and nuclear functions of RTKs, and discuss how they promote cancer progression, and their clinical implications.
© 2015 FEBS.

Entities:  

Keywords:  INTERNET; MRIN; RTK cleavage; intracellular trafficking; non-canonical RTK functions; nuclear receptor tyrosine kinases; nuclear translocation; proteolytic cleavage; receptor tyrosine kinase; retrograde trafficking

Mesh:

Substances:

Year:  2015        PMID: 26096795      PMCID: PMC4591179          DOI: 10.1111/febs.13342

Source DB:  PubMed          Journal:  FEBS J        ISSN: 1742-464X            Impact factor:   5.542


  262 in total

1.  EGFR nuclear translocation modulates DNA repair following cisplatin and ionizing radiation treatment.

Authors:  Gianmaria Liccardi; John A Hartley; Daniel Hochhauser
Journal:  Cancer Res       Date:  2011-01-25       Impact factor: 12.701

Review 2.  Complexity of receptor tyrosine kinase signal processing.

Authors:  Natalia Volinsky; Boris N Kholodenko
Journal:  Cold Spring Harb Perspect Biol       Date:  2013-08-01       Impact factor: 10.005

Review 3.  Cell signaling by receptor tyrosine kinases.

Authors:  Mark A Lemmon; Joseph Schlessinger
Journal:  Cell       Date:  2010-06-25       Impact factor: 41.582

4.  Nuclear localization of epidermal growth factor and epidermal growth factor receptors in human thyroid tissues.

Authors:  U Marti; C Ruchti; J Kämpf; G A Thomas; E D Williams; H J Peter; H Gerber; U Bürgi
Journal:  Thyroid       Date:  2001-02       Impact factor: 6.568

5.  Nuclear trafficking of FGFR1: a role for the transmembrane domain.

Authors:  Jason M Myers; Gabriel G Martins; Jacek Ostrowski; Michal K Stachowiak
Journal:  J Cell Biochem       Date:  2003-04-15       Impact factor: 4.429

Review 6.  Receptor tyrosine kinases: legacy of the first two decades.

Authors:  Joseph Schlessinger
Journal:  Cold Spring Harb Perspect Biol       Date:  2014-03-01       Impact factor: 10.005

7.  Nuclear localization of orphan receptor protein kinase (Ror1) is mediated through the juxtamembrane domain.

Authors:  Hsiao-Chun Tseng; Ping-Chiang Lyu; Wen-Chang Lin
Journal:  BMC Cell Biol       Date:  2010-06-30       Impact factor: 4.241

Review 8.  Adaptor proteins involved in polarized sorting.

Authors:  Juan S Bonifacino
Journal:  J Cell Biol       Date:  2014-01-06       Impact factor: 10.539

9.  Tissue inhibitor of metalloproteinases-1 promotes liver metastasis by induction of hepatocyte growth factor signaling.

Authors:  Charlotte Kopitz; Michael Gerg; Obul Reddy Bandapalli; Dilek Ister; Caroline J Pennington; Stephanie Hauser; Christin Flechsig; Hans-Willi Krell; Dalibor Antolovic; Keith Brew; Hideaki Nagase; Manfred Stangl; Claus W Hann von Weyhern; Björn L D M Brücher; Karsten Brand; Lisa M Coussens; Dylan R Edwards; Achim Krüger
Journal:  Cancer Res       Date:  2007-09-15       Impact factor: 12.701

10.  Expression of epidermal growth factor receptor in bladder cancer as related to established prognostic factors, oncoprotein (c-erbB-2, p53) expression and long-term prognosis.

Authors:  P Lipponen; M Eskelinen
Journal:  Br J Cancer       Date:  1994-06       Impact factor: 7.640

View more
  30 in total

1.  H2O2 induces nuclear transport of the receptor tyrosine kinase c-MET in breast cancer cells via a membrane-bound retrograde trafficking mechanism.

Authors:  Mei-Kuang Chen; Yi Du; Linlin Sun; Jennifer L Hsu; Yu-Han Wang; Yuan Gao; Jiaxing Huang; Mien-Chie Hung
Journal:  J Biol Chem       Date:  2019-04-08       Impact factor: 5.157

2.  VEGF-R1 as a Potential Molecular Target for Anticancer Therapy.

Authors:  E G Tyrsina; S I Nikulitskiy; A N Inshakov; O O Ryabaya
Journal:  Dokl Biochem Biophys       Date:  2018-03-14       Impact factor: 0.788

3.  The Drosophila Epidermal Growth Factor Receptor does not act in the nucleus.

Authors:  Maximilien Courgeon; Dan Qing He; Hui Hua Liu; Kevin Legent; Jessica E Treisman
Journal:  J Cell Sci       Date:  2018-09-20       Impact factor: 5.285

Review 4.  Nuclear ErbB-2: a Novel Therapeutic Target in ErbB-2-Positive Breast Cancer?

Authors:  Rosalía I Cordo Russo; María F Chervo; Santiago Madera; Eduardo H Charreau; Patricia V Elizalde
Journal:  Horm Cancer       Date:  2019-01-17       Impact factor: 3.869

Review 5.  Effective implementation of novel MET pharmacodynamic assays in translational studies.

Authors:  Apurva K Srivastava; Tony Navas; William G Herrick; Melinda G Hollingshead; Donald P Bottaro; James H Doroshow; Ralph E Parchment
Journal:  Ann Transl Med       Date:  2017-01

6.  IL-6/JAK1 pathway drives PD-L1 Y112 phosphorylation to promote cancer immune evasion.

Authors:  Li-Chuan Chan; Chia-Wei Li; Weiya Xia; Jung-Mao Hsu; Heng-Huan Lee; Jong-Ho Cha; Hung-Ling Wang; Wen-Hao Yang; Er-Yen Yen; Wei-Chao Chang; Zhengyu Zha; Seung-Oe Lim; Yun-Ju Lai; Chunxiao Liu; Jielin Liu; Qiongzhu Dong; Yi Yang; Linlin Sun; Yongkun Wei; Lei Nie; Jennifer L Hsu; Hui Li; Qinghai Ye; Manal M Hassan; Hesham M Amin; Ahmed O Kaseb; Xin Lin; Shao-Chun Wang; Mien-Chie Hung
Journal:  J Clin Invest       Date:  2019-07-15       Impact factor: 14.808

7.  Proteolytic Processing of SERK3/BAK1 Regulates Plant Immunity, Development, and Cell Death.

Authors:  Jinggeng Zhou; Ping Wang; Lucas A N Claus; Daniel V Savatin; Guangyuan Xu; Shujing Wu; Xiangzong Meng; Eugenia Russinova; Ping He; Libo Shan
Journal:  Plant Physiol       Date:  2019-02-19       Impact factor: 8.340

8.  Regulation of therapeutic resistance in cancers by receptor tyrosine kinases.

Authors:  Mei-Kuang Chen; Mien-Chie Hung
Journal:  Am J Cancer Res       Date:  2016-03-15       Impact factor: 6.166

9.  EphA2 receptor is a key player in the metastatic onset of Ewing sarcoma.

Authors:  Silvia Garcia-Monclús; Roser López-Alemany; Olga Almacellas-Rabaiget; David Herrero-Martín; Juan Huertas-Martinez; Laura Lagares-Tena; Piedad Alba-Pavón; Lourdes Hontecillas-Prieto; Jaume Mora; Enrique de Álava; Santi Rello-Varona; Paloma H Giangrande; Oscar M Tirado
Journal:  Int J Cancer       Date:  2018-04-16       Impact factor: 7.396

10.  The Extracellular Matrix Receptor Discoidin Domain Receptor 1 Regulates Collagen Transcription by Translocating to the Nucleus.

Authors:  Manuel Chiusa; Wen Hu; Hong-Jun Liao; Yan Su; Corina M Borza; Mark P de Caestecker; Nataliya I Skrypnyk; Agnes B Fogo; Vadim Pedchenko; Xiyue Li; Ming-Zhi Zhang; Billy G Hudson; Trayambak Basak; Roberto M Vanacore; Roy Zent; Ambra Pozzi
Journal:  J Am Soc Nephrol       Date:  2019-08-05       Impact factor: 10.121

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.